Novartis Q4 Results slide image

Novartis Q4 Results

↓ ↑ Content Click below to navigate through the document Company overview Financial review Conclusions Appendix References Financial review and 2024 guidance Harry Kirsch Chief Financial Officer □ NOVARTIS Reimagining Medicine
View entire presentation